NOT-HG-24-014: Notice of Early Expiration and Reissuance of RFA-HG-24-006: "NHGRI Technology Development Coordinating Center (U24 Clinical Trial Not Allowed)"

Notice of Early Expiration and Reissuance of RFA-HG-24-006: "NHGRI Technology Development Coordinating Center (U24 Clinical Trial Not Allowed)"

Notice Number:

NOT-HG-24-014

Key Dates

Release Date:

January 12, 2024

Related Announcements

January 12,2024 - NHGRI Technology Development Coordinating Center (U24 Clinical Trial Not Allowed). See NOFO RFA-HG-24-013.
January 2, 2024 - NHGRI Technology Development Coordinating Center (U24 Clinical Trial Not Allowed). See NOFO RFA-HG-24-006.

Issued by

National Human Genome Research Institute (NHGRI)

Purpose

This Notice is to inform the research community of the early expiration of RFA-HG-24-006, NHGRI Technology Development Coordinating Center (U24 Clinical Trial Not Allowed), effective immediately. NHGRI plans to reissue this request for applications as RFA-HG-24-013 with updated review criteria and with the application due date of the original RFA preserved (April 2, 2024). Applicants are encouraged to consider applying to the new NOFO (expected to be published in January 2024): RFA-HG-24-013, "NHGRI Technology Development Coordinating Center (U24 Clinical Trial Not Allowed)".

In summary:

The expired request for applications is RFA-HG-24-006
The reissued request for applications is RFA-HG-24-013

Inquiries

Please direct all inquiries to:

Stephanie A. Morris, Ph.D.
National Human Genome Research Institute (NHGRI)
Telephone: 301-435-5738
Email: morriss2@mail.nih.gov